RxDoctor Payments Data

Stacy Corum

Women's Health · Merriam, KSNPI 1609275502

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,645in general payments, 2019–2025

Across 201 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$600
  • Mayne Pharma Commercial LLC$528
  • Biogen$502
  • Daiichi Sankyo Inc.$205
  • Aspira Women's Health Inc$196
  • Astellas Pharma US Inc$177
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,632100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,645 in reported general payments places this provider in the 95th percentile of 43 women's health providers in Kansas.

See all women's health providers in Kansas

Medicare billing

Part B allowed, 2024
$2,455
Medicare patients
40
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol33$1,720
ApriDesogestrel-Ethinyl Estradiol20$517

Paid to pharmacies, not to this prescriber.

Other women's health in Merriam

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →